1. Home
  2. ARCC vs DVA Comparison

ARCC vs DVA Comparison

Compare ARCC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

HOLD

Current Price

$18.06

Market Cap

13.6B

Sector

Finance

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$209.42

Market Cap

13.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCC
DVA
Founded
2004
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
13.5B
IPO Year
2004
2003

Fundamental Metrics

Financial Performance
Metric
ARCC
DVA
Price
$18.06
$209.42
Analyst Decision
Buy
Hold
Analyst Count
11
4
Target Price
$21.36
$156.75
AVG Volume (30 Days)
4.8M
594.4K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
10.28%
N/A
EPS Growth
N/A
N/A
EPS
0.13
2.87
Revenue
N/A
$13,643,069,000.00
Revenue This Year
$5.77
$3.85
Revenue Next Year
$2.29
$3.07
P/E Ratio
$138.69
$72.41
Revenue Growth
N/A
6.46
52 Week Low
$17.40
$101.00
52 Week High
$23.42
$213.44

Technical Indicators

Market Signals
Indicator
ARCC
DVA
Relative Strength Index (RSI) 34.23 68.51
Support Level $17.49 $189.09
Resistance Level $19.38 N/A
Average True Range (ATR) 0.29 5.84
MACD -0.10 0.38
Stochastic Oscillator 0.39 82.56

Price Performance

Historical Comparison
ARCC
DVA

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

About DVA DaVita Inc.

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Share on Social Networks: